2Rosen P P. Rosen~ breast pathology[ M]. 3rd ed. Philadelphia:Lippincott Williams & Wilkins, 2009:590-604.
3Sumpio B E, Jennings T A, Merino M J, Sullivan P D. Adenoid cystic carcinoma of the breast. Data from the Connecticut Tumor Registry and a review of the literature [ J]. Ann Surg, 1987,205 (3) :295 -301.
4Tavassoli F A, Devilee P. World Health Orgnaniztion classification of tumours. Pathology and genetics, turnouts of the breast and fe- male genital organs[ M]. Lyon: IARC Press, 2003:44 -5.
5Shin S J, Rosen P P. Solid variant of mammary adenoid cystic car- cinoma with basaloid features: a study of nine cases [ J ]. Am J Surg Pathol, 2002,26(4) :413 -20.
6Ro J Y, Mackay B, Batsakis J G, et al. Intraluminal crystalloids in malignant salivary gland tumors ( electron microscopic and X-ray microanalytic studies) [ J ]. J Laryngol Otol, 1987,101 ( 11 ) : 1175 -81.
7Mastropasqua M G, Maiorano E, Pruneri G, et aL Immunoreac- tivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast[ J]. Mod Pathol, 2005,18 (10) : 1277 - 82.
8Azoulay S, Lae M, Freneaux P, et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma as- sociated with a favorable outcome [ J ]. Mod Pathol, 2005, 18 (12):1623 -31.
9Arpino G, Clark G M, Mohsin S, et al. Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome [J]. Cancer, 2002,94(8) :2119 -27.
10Kleer C G, Oberman H A. Adenoid cystic carcinoma of the breast: value of histologic grading and proliferative activity [ J ]. Am J Surg Pathol, 1998,22(5) :569 -75.